Though late by a few weeks because of other life events, Rosha and I are thrilled to be shipping up to Boston for my residency this June! There isn’t a better city for the both of us in terms of professional opportunities in terms of my training at Boston Children’s Hospital, and the plethora of opportunities available to Rosha in the biotech / pharm industry that Boston has to offer.
It has been one chaotic ride these past few months, between our first wedding in Nepal, a second wedding in America, and a conference in Berlin, it has been one heckuva interview season. It was a real treat to be able to travel and have the chance to interview at several places, seeing how different programs are structured and function. While my thoughts were that any outcome was a good decision, as it would allow me to do what I wanted, we are quite ecstatic about the chance to move to Boston for the betterment of both of our careers.
With the stress and chaos of Match behind us, my advice to rising M4s about to embark on the terrifying journey of match is to: trust your instinct, enjoy the process, realize what matters most to you,
Trust your instinct. The bulk of residency training is going to be the same between institutions and it really is your colleagues that make/break your training experience. Initially, I tried making all sorts of complicated excel spreadsheets and algorithms ranking different variables between programs (research opportunities, city life, primary vs. specialty training, etc…). After a few interviews, I realized that these differences were rather subtle between programs, and that ultimately, the best indicator of programs was my voice’s excitement of my phone calls to my wife after the interviews. Anywhere you go, you end up as a well trained physician.
Enjoy the process. My general rule of thumb was to not rush into/out of interviews, and to stay a day before and after the interviews to tour the city and neighborhoods around. Granted, this meant sleeping on someone’s couch an extra day or two, but frankly, to me it was really important to tour the city to see where I am going to be calling home for the next 5 years. Also, the Match interviews are entirely different than Medical School interviews. Where, in medical school, you just want “someone to take you!” However, in the match interviews, the roles are flipped, as programs realize they have many qualified candidates and go out of their way to sell their program to you, wanting you to come to their program. Certainly, you must appropriately prepare for the interviews, but letting your personality shine through can really go a long way in the interview process. It’s a strange sensation feeling wanted, but something definitely worth enjoying for a change.
What matters most: Perhaps most importantly, realizing what is most important to you as you embark on the next personal and professional chapter of your life is probably the most important factor influencing the match decision. Are family and location most important? Are you geographically focused on a particular area for any number of reasons, or conversely, do you want to explore somewhere new and exciting? What else matters in your rank list: reputation, camaraderie, or subspecialty or primary focuses? Asking these sort of questions for yourself will help you identify which institution and city will help you become the best version of yourself.
As archaic and convoluted as it may seem, the match process ultimately is best attempt to make the process as organized and fair as possible. Though, for many Type A’s of medical school, the lack of control is intimidating and daunting, the match process ultimately works out best for just about everyone involved!
With much dividing discussion surrounding the debates about guns and their associated violence, I took the opportunity to share my thoughts and opinions in the Gainesville Sun through an Op-Ed. In response to Rick Scott signing the first gun law in 30 years, I talk about how guns are a part of the American DNA, and how this is not necessarily a good thing. Though well intended gun owners intend to prevent death and harm with their guns, there are 34 criminal homicides, 78 gun suicides, and 2 accidental deaths for every crime prevented or justifiable homicide. Furthermore, there is bipartisan support for common sense gun laws, something that evades current governmental legislators. In response to the Parkland shooting, we, as Floridians, have a chance to lay the groundwork for a slow and long overhaul of the current gun laws to provide safety to our citizens. After all, which is more important: the right to gun ownership, or the right to health and safety?
In the March 2018 Florida Chapter of the American Academy of Pediatrics, we published a brief article to better understand and provide information about the troubles that non-citizens, particularly children, face in this country.
Healthcare for Non-Citizen Children
What is a non-citizen?
Who are we talking about?
Why does this matter?
Where do you get healthcare as a non-citizen?
Health consequences to immigrant children
Where do we go from here?
Resources for medical students and healthcare professionals:
Resources for pediatric patients and their families:
Resources to get involved with policymakers
Contrast-Enhanced Near-Infrared Optical Imaging Detects Exacerbation and Amelioration of Murine Muscular Dystrophy
In our most recent article, in Molecular Imaging, we explore the potential to use Near Infrared Optical Imaging as a biomarker to assess muscle pathology secondary to disease processes, specifically two variants of muscular dystrophy. As these diseases are progressive by nature, it is important to be able assess progression of disease. With the rapid pipeline of treatments reaching clinical trials, it was equally important to be able to assess mitigation of disease. Overall, we demonstrate the ability to utilize this technology to further assess worsening and reversal of muscle pathology in two disease states.
During the recent Imaging in Neuromuscular Disease 2017 conference held in Berlin, I took the opportunity to venture away from the conference to visit the Berlin Wall Memorial. Though constructed for different purposes, walls inevitably and always isolate and exclude. With much racist, xenophobic, and ignorantly blind patriotism permeating America's current political scene, I composed an Op-Ed, published in the Gainesville Sun, in an attempt to remind ourselves of our history to avoid repeating such a past. After all, America is the land of immigrants, and building walls is counterintuitive to our core American values.
Deflazacort, a glucocorticoid that has been used off-label for years to mitigate the disease progression of Duchenne muscular dystrophy (DMD) was recently given formal approval by the FDA for use in DMD. This formal approval requires patients and families to now purchase the drug, even if they have been inexpensively using it for years, from a single pharmaceutical company for significantly higher prices. The increased price of Deflazacort has caused much concern and burden to patient families, who previously had been using it safely for years, but are not required to purchase it for elevated prices.
Rosha and I took the opportunity to write a viewpoint in JAMA Neurology to voice our concerns over the new costs of this old medicine.
The MD-PhD training experience is uniquely filled with transition points between medical and graduate training. These transitions are frequently a time of stress and anxiety because of cultural paradigm shifts between the different training periods, accentuated by different paces, teaching styles, learning approaches, and overall culture. Frequently, the most dreaded transition is the return to the clinic after completion of the PhD. In the recently published editorial in the Medical Science Educator, I try to mitigate some of the stresses and concerns that students face through programs implemented across the country and through my own experiences.
In April 2015, Nepal experienced one of the worst earthquakes in the country's history, devastating an already troubled infrastructure. Feeling helpless from America, Rosha and I helped fundraise and planned a trip to help with the rebuilding efforts. We wanted to help with our boots on the ground rather than donating to organizations without knowing how the charity will directly help the victims.
One of our goals for the trip was to help an elementary school that was run by family friends in Harmi, Gorkha - in one of the most remote and hardest hit areas of Nepal. After Rosha raised ~$7,000, we were able to purchase the materials necessary to rebuild the school, and after discussions with locals and village leaders, brought all of the supplies to Harmi.
Unfortunately, we had to return to America before we could see the final product. Through the marvels of the internet, we were able to contact one of the village leaders, who was able to provide us with photos of the completed school!
With a love for data, like all scientists, and keenly interested in my own health, I was curious how the gauntlet of clerkships through the M3 year actually affect our health. I frequently joke that going through medical school is the worst thing I've ever done for my body, so I sought to back it up with supportive data. Granted, this is only an n of 1, and the plural of anecdote is not always data, but I thought it'd still be interesting to look at.
As a precursor, prior to this year, my baseline running was ~25 miles every 2 weeks, so from the beginning, you can see that only once did I reach during the whole year. My weight for several years prior hovered in the low 170s. Leading up to my dissertation defense (immediately prior to the data here), I was already neglecting my body and weight, as you can see.
It seems like Family and Psych were certainly the most conducive to maintaining my health, while OB/GYN and Surgery were not. The diet definitely suffered in regards to quality during those months as well. I didn't realize I ran so much during surgery, but it was probably me recouping during all of the post-call days.
During the past medical school year, I had the privilege to be present as our pediatric neurology team helped administer the first drug approved by the FDA to treat the underlaying cause of Duchenne Muscular Dystrophy. Because of my vested personal interests in DMD, I wrote a brief editorial in Pediatric Neurology, highlighting the momentous occasion that was worth celebrating. Much work certainly still needs to be done, but for a brief moment, this was worth celebrating.
I'm a current MD-PhD candidate, working hard to help treat and manage muscular dystrophies